SARS-CoV-2 (COVID-19) Nucleocapsid Monoklonale Antilichaam [N014]

Fully humanized monoclonal antibody paired with human monoclonal antibody LOCUS:QHD43423 419aa linear VRL 18-MAR-2020 DEFINITION:nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2]. ACCESSION:QHD43423 VERSION:QHD43423.2 DBSOURCE:accession MN908947.3 SOURCE:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORGANISM:Viruses; Riboviria; Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae; Betacoronavirus; Sarbecovirus.

43740575

QHD43423.2

Virus

Nucleocapsid recombinant protein

N014

Unconjugated

Primary Antibodies

Infectious Disease, COVID-19

Greater than 95% as determined by reducing SDS-PAGE.

Batch dependent

PBS with 0.02% sodium azide, 10% glycerol, pH7.2

None

Blue Ice

Store at 4˚ C short term. Aliquot and store at -20˚ C long term. Avoid freeze-thaw cycles.

ELISA: 1:160000; WB: 1:2000~3000

N

Nucleocapsid phosphoprotein

SARS-CoV-2

SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Nucleocapsid Phosphoprotein, Nucleocapsid protein

ELISA, WB

Liquid